REQUEST A DEMO
Total
USD $0.00
Search more companies

Pt Guna Abdi Wisesa (Indonesia)

Main Activities: Pharmaceutical Preparation Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Pt Guna Abdi Wisesa Profile Updated: November 14, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Pt Guna Abdi Wisesa is an enterprise located in Indonesia, with the main office in Central Jakarta. The company operates in the Pharmaceutical Preparation Manufacturing sector. It was incorporated on November 30, 1981. The latest financial highlights indicate a net sales revenue increase of 9.91% in 2024. Its’ total assets recorded a growth of 12.56%.

Headquarters
RT 001, RW 004
Central Jakarta; Jakarta; Postal Code: 10630

Contact Details: Purchase the Pt Guna Abdi Wisesa report to view the information.

Website: http://www.gaw.co.id

Basic Information
Registered Capital:
Purchase the Pt Guna Abdi Wisesa report to view the information.
Financial Auditors:
Purchase the Pt Guna Abdi Wisesa report to view the information.
Incorporation Date:
November 30, 1981
Key Executives
Purchase this report to view the information.
President Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Commissioner
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Pt Guna Abdi Wisesa report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IDR. Absolute financial data is included in the purchased report.
Net sales revenue
9.91%
Total Operating Revenue
9.91%
Total Assets
12.56%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?